← Leaderboards
Grace M Lee
Harvard Pilgrim Health Care, Inc.
$5,759,826
Attributed
$5,759,826
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
AHRQ$5,312,670 · 3
NIH$447,156 · 1
By mechanism
R01$3,440,484 · 1
R18$1,484,979 · 1
R21$447,156 · 1
K08$387,207 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Pilgrim Health Care, Inc.
Same institution · by research overlap
- Sharon Marie Lutz$4,183,985
Others in their field
Top investigators on “Health Care Quality”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- James Dennis Neaton · Northwestern University$203,539,316
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$198,115,770
- Abhik Das · Research Triangle Institute$152,924,398
Research focus
Health Care QualityHigh RiskCaringAdmission ActivityAffectBehaviorAntibiotic ProphylaxisCarrots - DietaryCatheter Associated UtiCessation Of LifeBaseCoronary Artery BypassFutureHealthcareDiagnosisDisease /Disorder Prevention /ControlDisincentiveEconomic BurdenElementsEnsureEnvironmentEvaluationFinancial IncentiveHospitalization
Grant awards (16)
Defining and Preventing Ventilator-Associated Complications in Pediatrics$498,189
R18 · FY2015 · HS · contact PI
Preventing Avoidable Infectious Complications by Adjusting Payment (PAICAP)II$1,249,788
R01 · FY2014 · HS · contact PI
Defining and Preventing Ventilator-Associated Complications in Pediatrics$499,999
R18 · FY2014 · HS · contact PI
Defining and Preventing Ventilator-Associated Complications in Pediatrics$486,791
R18 · FY2013 · HS · contact PI
Intended and Unintended Consequences of Nonpayment for Preventable Complications$242,945
R01 · FY2013 · HS · contact PI
Intended and Unintended Consequences of Nonpayment for Preventable Complications$488,725
R01 · FY2012 · HS · contact PI
Intended and Unintended Consequences of Nonpayment for Preventable Complications$485,940
R01 · FY2011 · HS · contact PI
Intended and Unintended Consequences of Nonpayment for Preventable Complications$489,276
R01 · FY2010 · HS · contact PI
Nonpayment for Preventable Complications: Impact on Hospital Practices and Health$194,160
R21 · FY2010 · AI · contact PI
Intended and Unintended Consequences of Nonpayment for Preventable Complications$483,810
R01 · FY2009 · HS · contact PI
Nonpayment for Preventable Complications: Impact on Hospital Practices and Health$252,996
R21 · FY2009 · AI · contact PI
Strategies for Group A Streptococcal Prevention$128,979
K08 · FY2008 · HS · contact PI
Strategies for Group A Streptococcal Prevention$128,493
K08 · FY2007 · HS · contact PI
Strategies for Group A Streptococcal Prevention$129,735
K08 · FY2006 · HS · contact PI
Strategies for Group A Streptococcal Prevention$0
K08 · FY2005 · HS
Strategies for Group A Streptococcal Prevention$0
K08 · FY2004 · HS